Ling Wang

Ling Wang is a Clinical Data Scientist at DRT Strategies since February 2023, collaborating with clinical reviewers in the Office of New Drugs within the Center for Drug Evaluation and Research. Prior experience includes serving as a Postdoctoral Scholar at The University of Chicago Pritzker School of Medicine from September 2019 to August 2022, where expertise in NGS omics data and clinical data was leveraged through collaboration with multi-disciplinary teams, including federal agencies and industry partners. Ling Wang worked as a Postdoctoral Researcher and Graduate Research/Teaching Assistant at North Carolina State University from August 2010 to September 2019, focusing on microbiology, microbial ecology, bioinformatics, and genomics. Educational qualifications include a PhD in Civil Engineering & Biotechnology from North Carolina State University and an MS in Environmental Engineering from the same institution, along with a BS in Environmental Engineering from National Cheng Kung University.